5-(2-Bromoethoxy)-2,3-dihydro-1,4-benzodioxine, 97.0%, 25g

(R)-1-(Pyridin-2-yl)ethanamine, 95.0%, 25g

Z-D-His-OH, 95+%, 1g

Tetrahydro-2H-thiopyran-4-carbaldehyde 1,1-dioxide, 98%, 250mg

2,5-Dimethyl-1-(3-nitrophenyl)-1h-pyrrole-3-carbaldehyde, 97%, 5g

tert-Butyl 4-hydrazinylpiperidine-1-carboxylate 4-methylbenzenesulfonate, 97%, 5g

1,4-dimethyl-5-nitro-1H-imidazole, 1g

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2h-pyrazolo[3,4-b]pyridine, 98%, 250mg

1-Iodo-4-(pentafluorosulfanyl)benzene, 99.0%, 250mg

N-((4-(4-PHENYLPIPERAZIN-1-YL)TETRAHYDRO-2H-PYRAN-4-YL)METHYL)-2-(PHENYLTHIO)NICOTINAMIDE, 95%, 5mg

Pointes de pipettes 0,5-20 μl, Unité de recharge (palettisée), Non stérile, 960 pièces

2-(1H-Pyrrol-2-yl)pyridine, 97%, 5g

Methyl 2-bromo-3,3-dimethoxypropanoate, 97%, 25g